These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
237 related articles for article (PubMed ID: 27394186)
1. The effects of ripasudil (K-115), a Rho kinase inhibitor, on activation of human conjunctival fibroblasts. Futakuchi A; Inoue T; Fujimoto T; Inoue-Mochita M; Kawai M; Tanihara H Exp Eye Res; 2016 Aug; 149():107-115. PubMed ID: 27394186 [TBL] [Abstract][Full Text] [Related]
2. Effects of Ripasudil, a Rho-Kinase Inhibitor, on Scar Formation in a Mouse Model of Filtration Surgery. Ko JA; Komatsu K; Minamoto A; Kondo S; Okumichi H; Hirooka K; Kiuchi Y Curr Eye Res; 2023 Sep; 48(9):826-835. PubMed ID: 37216470 [TBL] [Abstract][Full Text] [Related]
3. An in vitro study of scarring formation mediated by human Tenon fibroblasts: Effect of Y-27632, a Rho kinase inhibitor. Ibrahim DG; Ko JA; Iwata W; Okumichi H; Kiuchi Y Cell Biochem Funct; 2019 Mar; 37(2):113-124. PubMed ID: 30773659 [TBL] [Abstract][Full Text] [Related]
4. Rosiglitasone and ROCK Inhibitors Modulate Fibrogenetic Changes in TGF-β2 Treated Human Conjunctival Fibroblasts (HconF) in Different Manners. Oouchi Y; Watanabe M; Ida Y; Ohguro H; Hikage F Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34298955 [TBL] [Abstract][Full Text] [Related]
5. Potential role of Rho-associated protein kinase inhibitor Y-27632 in glaucoma filtration surgery. Honjo M; Tanihara H; Kameda T; Kawaji T; Yoshimura N; Araie M Invest Ophthalmol Vis Sci; 2007 Dec; 48(12):5549-57. PubMed ID: 18055804 [TBL] [Abstract][Full Text] [Related]
6. Human anti-transforming growth factor-beta2 antibody: a new glaucoma anti-scarring agent. Cordeiro MF; Gay JA; Khaw PT Invest Ophthalmol Vis Sci; 1999 Sep; 40(10):2225-34. PubMed ID: 10476787 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of Chitosan/Aptamer Targeting TGF-β Receptor II Thermo-Sensitive Gel for Scarring in Rat Glaucoma Filtration Surgery. Zhu X; Xu D; Zhu X; Li L; Li H; Guo F; Chen X; Tan Y; Xie L Invest Ophthalmol Vis Sci; 2015 Aug; 56(9):5465-76. PubMed ID: 26284552 [TBL] [Abstract][Full Text] [Related]
8. Valproic acid suppresses collagen by selective regulation of Smads in conjunctival fibrosis. Seet LF; Toh LZ; Finger SN; Chu SW; Stefanovic B; Wong TT J Mol Med (Berl); 2016 Mar; 94(3):321-34. PubMed ID: 26507880 [TBL] [Abstract][Full Text] [Related]
9. Molecular Mechanisms Underlying the Filtration Bleb-Maintaining Effects of Suberoylanilide Hydroxamic Acid (SAHA). Futakuchi A; Inoue T; Fujimoto T; Kuroda U; Inoue-Mochita M; Takahashi E; Ohira S; Tanihara H Invest Ophthalmol Vis Sci; 2017 Apr; 58(4):2421-2429. PubMed ID: 28448670 [TBL] [Abstract][Full Text] [Related]
10. SB-431542 inhibition of scar formation after filtration surgery and its potential mechanism. Xiao YQ; Liu K; Shen JF; Xu GT; Ye W Invest Ophthalmol Vis Sci; 2009 Apr; 50(4):1698-706. PubMed ID: 19098325 [TBL] [Abstract][Full Text] [Related]
11. Inhibition by all-trans-retinoic acid of transforming growth factor-β-induced collagen gel contraction mediated by human tenon fibroblasts. Liu Y; Kimura K; Orita T; Teranishi S; Suzuki K; Sonoda KH Invest Ophthalmol Vis Sci; 2014 Jun; 55(7):4199-205. PubMed ID: 24894398 [TBL] [Abstract][Full Text] [Related]
12. Time Course of Conjunctival Hyperemia Induced by a Rho-kinase Inhibitor Anti-glaucoma Eye Drop: Ripasudil 0.4. Terao E; Nakakura S; Fujisawa Y; Fujio Y; Matsuya K; Kobayashi Y; Tabuchi H; Yoneda T; Fukushima A; Kiuchi Y Curr Eye Res; 2017 May; 42(5):738-742. PubMed ID: 27911106 [TBL] [Abstract][Full Text] [Related]
13. Suppression of transforming growth factor-β effects in rabbit subconjunctival fibroblasts by activin receptor-like kinase 5 inhibitor. Sapitro J; Dunmire JJ; Scott SE; Sutariya V; Geldenhuys WJ; Hewit M; Yue BY; Nakamura H Mol Vis; 2010 Sep; 16():1880-92. PubMed ID: 21031133 [TBL] [Abstract][Full Text] [Related]
14. DNA methyltransferase inhibitor suppresses fibrogenetic changes in human conjunctival fibroblasts. Yonemura H; Futakuchi A; Inoue-Mochita M; Fujimoto T; Takahashi E; Tanihara H; Inoue T Mol Vis; 2019; 25():382-390. PubMed ID: 31523116 [TBL] [Abstract][Full Text] [Related]
15. YAP/TAZ Are Essential for TGF-β2-Mediated Conjunctival Fibrosis. Futakuchi A; Inoue T; Wei FY; Inoue-Mochita M; Fujimoto T; Tomizawa K; Tanihara H Invest Ophthalmol Vis Sci; 2018 Jun; 59(7):3069-3078. PubMed ID: 30025139 [TBL] [Abstract][Full Text] [Related]
16. Contractility as a prerequisite for TGF-beta-induced myofibroblast transdifferentiation in human tenon fibroblasts. Meyer-ter-Vehn T; Sieprath S; Katzenberger B; Gebhardt S; Grehn F; Schlunck G Invest Ophthalmol Vis Sci; 2006 Nov; 47(11):4895-904. PubMed ID: 17065504 [TBL] [Abstract][Full Text] [Related]
17. The involvement of the rho-kinase pathway and its regulation in cytokine-induced collagen gel contraction by hyalocytes. Hirayama K; Hata Y; Noda Y; Miura M; Yamanaka I; Shimokawa H; Ishibashi T Invest Ophthalmol Vis Sci; 2004 Nov; 45(11):3896-903. PubMed ID: 15505034 [TBL] [Abstract][Full Text] [Related]
18. Critical role of the Rho-kinase pathway in TGF-beta2-dependent collagen gel contraction by retinal pigment epithelial cells. Miura M; Hata Y; Hirayama K; Kita T; Noda Y; Fujisawa K; Shimokawa H; Ishibashi T Exp Eye Res; 2006 May; 82(5):849-59. PubMed ID: 16310190 [TBL] [Abstract][Full Text] [Related]
19. All‑trans‑retinoic acid modulates TGF‑β‑induced apoptosis, proliferation, migration and extracellular matrix synthesis of conjunctival fibroblasts by inhibiting PI3K/AKT signaling. Liang L; Wang X; Zheng Y; Liu Y Mol Med Rep; 2019 Sep; 20(3):2929-2935. PubMed ID: 31322252 [TBL] [Abstract][Full Text] [Related]
20. Rho kinase inhibitor AMA0526 improves surgical outcome in a rabbit model of glaucoma filtration surgery. Van de Velde S; Van Bergen T; Vandewalle E; Kindt N; Castermans K; Moons L; Stalmans I Prog Brain Res; 2015; 220():283-97. PubMed ID: 26497796 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]